Akums Drugs and Pharmaceuticals IPO - RHP Updates & Quick Thoughts on Peer Comp and Valuation

235 Views26 Jul 2024 13:00
Akums Drugs and Pharmaceuticals is looking to raise up to US$222m in its upcoming India IPO. In this note, we talk about its RHP updates and share our quick thoughts on peer comparison and valuation.
What is covered in the Full Insight:
  • RHP Updates
  • Performance and Financial Metrics FY24
  • Peer Comparison
  • Valuation Analysis
  • Conclusion and Investment Recommendation
SUMMARY
(Sign Up to Access)
Get started on the Smartkarma Research Network with a complimentary Preview Pass to:
  • Unlock all research summaries
  • Follow top, independent analysts
  • Receive personalised alerts and emails
  • Access Briefings, Analytics, and Events

Upgrade anytime to our paid plans for full-length research, real-time analyst discussions, and more.

Join a thriving community of 45,000+ investors, including the top global asset managers managing over $13trn in assets.

or
Already have an account? Sign In Now
Full Insight
(Paid Plans Only, 5-minute read)
Discussions
(Paid Plans Only)
chart-bar
Logo
Top 5%
Ethan Aw
APAC IPOs & Placements
Aequitas Research
EquitiesEquity Capital Markets
Price Chart(Sign Up to Access)
analytics-chart
x